Bonus BioGroup Ltd. (TLV:BONS)
39.60
-0.10 (-0.25%)
May 20, 2026, 5:24 PM IDT
Bonus BioGroup Company Description
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.
The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-threatening acute inflammatory diseases.
Its products in pipeline comprise bone augmentation in osteoporosis patients; novel nano-materials for drug delivery; vascularized bone grafts; and soft tissue grafts.
The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.
Bonus BioGroup Ltd.
| Country | Israel |
| Founded | 1981 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 42 |
| CEO | Shai Meretzki |
Contact Details
Address: Matam Advanced Technology Park Haifa Israel | |
| Phone | 972 7 3206 7100 |
Stock Details
| Ticker Symbol | BONS |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0004850116 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shai Meretzki Ph.D. | Founder, Chief Executive Officer, President and Director |
| Joseph Rauch M.B.A. | Executive Chairman of the Board |
| Meital Enbar CPA | Vice President of Finance |
| Dr. Dror Ben David Ph.D. | Chief Operations Officer |
| Dr. Tomer Bronshtein Ph.D. | Vice President of Innovation and Corporate Development |
| Dr. Vered Kivity M.B.A., Ph.D. | Head of Regulatory Affairs and Vice President of Clinical Affairs |